亚太诊断成像市场至 2028 年的预测 – COVID-19 影响和区域分析 – 按模态分类 [X 射线、计算机断层扫描、内窥镜检查、超声波、磁共振成像 (MRI)、核成像、乳房 X 线摄影等] 、应用(心脏病学、肿瘤学、神经病学、骨科、胃肠病学、妇产科等)和最终用户(医院和诊所、诊断成像中心、门诊手术中心等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 177    |    Report Code: BMIRE00026160    |    Category: Life Sciences

Asia Pacific Diagnostic Imaging Market

亚太地区诊断成像市场预计将从2021年的7,818.99百万美元增长到11,572.58美元到2028年跨度>百万;预计 2021 年至 2028 年复合年增长率为 6.8%。

 

人工智能有助于改善医疗保健行业,诊断成像技术是受益匪浅的领域之一。全球诊断成像设备制造商正在将人工智能集成到他们的产品中。例如,2018年9月,Nvidia宣布推出Nvidia Clara平台,这是诊断成像设备中软件和硬件的组合。这种突破性的技术可以解决医疗仪器的挑战,并处理每秒生成的大量数据,让医生和科学家可以轻松解读。此外,2018 年 8 月,谷歌 DeepMind 宣布推出一款人工智能系统,可以通过常规医学扫描快速检测 50 多种眼部疾病。 DeepMind 的诊断成像人工智能助手可以在几秒钟内识别疾病症状并优先考虑寻求紧急护理的患者,从而自动解决与眼睛相关的问题。 AI支持的诊断成像设备在癌症的诊断和分类中发挥着至关重要的作用。人工智能在执行诊断成像任务时自动识别医学图像样本特征方面发挥着关键作用。例如,自动化人工智能应用程序增强了临床医生的定性潜力,包括一次检测患者中的大量肿瘤病变、通过在短时间内参考各种数据库来预测由此产生的肿瘤、将表型变异转化为基因型以及持续监测的患者。此外,人工智能以最小的错误推广了疾病成像技术,从而可以更早、更重要地诊断疾病。

 

凭借新的功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动亚太诊断成像市场实现大幅复合年增长率。

 

 亚洲到 2028 年太平洋诊断成像市场收入及预测(百万美元)

 

 

 

亚太诊断影像市场细分

 

亚太诊断成像市场根据模式、应用、最终用户和国家/地区进行细分。根据模式,市场分为 X 射线、计算机断层扫描、内窥镜检查、超声波、磁共振成像 (MRI)、核成像、乳房 X 线摄影等。 2021 年,计算机断层扫描领域占据最大的市场份额。预计在预测期内复合年增长率最高。根据应用,亚太诊断成像市场分为心脏病学、肿瘤学、神经学、骨科、胃肠病学、妇产科等。心脏病学领域在 2021 年占据最大的市场份额,肿瘤学领域预计在预测期内复合年增长率最高。根据最终用户,市场分为医院和诊所、诊断成像中心、门诊手术中心(ASC)等。 2021年,医院和诊所领域占据最大的市场份额。然而,诊断成像中心领域预计在预测期内复合年增长率最高。按国家/地区划分,亚太地区诊断成像市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。 2021年,中国占据最大的市场份额。预计在预测期内复合年增长率最高。

 

通用电气公司;西门子医疗;皇家飞利浦公司;卡尔史托斯公司两合公司;富士胶片控股公司;佳能公司;豪洛吉公司;锐珂健康公司;史赛克公司;和奥林巴斯公司是亚太诊断成像市场的领先公司。



Asia Pacific Diagnostic Imaging Strategic Insights

Strategic insights for Asia Pacific Diagnostic Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-diagnostic-imaging-market-strategic-framework.webp
Get more information on this report

Asia Pacific Diagnostic Imaging Report Scope

Report Attribute Details
Market size in 2021 US$ 7,818.99 Million
Market Size by 2028 US$ 11,572.58 Million
Global CAGR (2021 - 2028) 6.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 设备
  • 心电图
  • 起搏器
  • 支架
  • 除颤器
  • 心导管
  • 导丝
  • 心脏瓣膜
  • 事件监视器
By 应用
  • 冠心病
  • 心脏骤停
  • 中风
  • 脑血管心脏病
By 最终用户
  • 医院
  • 门诊手术中心
  • 心脏中心
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • General Electric Company
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • KARL STORZ SE & Co. KG
  • FUJIFILM Holdings Corporation
  • Canon Inc.
  • Hologic, Inc.
  • Carestream Health Inc.
  • Stryker Corporation
  • Olympus Corporation
  • Get more information on this report

    Asia Pacific Diagnostic Imaging Regional Insights

    The regional scope of Asia Pacific Diagnostic Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-diagnostic-imaging-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Diagnostic Imaging Market

    1. General Electric Company
    2. Siemens Healthineers
    3. Koninklijke Philips N.V.
    4. KARL STORZ SE & Co. KG
    5. FUJIFILM Holdings Corporation
    6. Canon Inc.
    7. Hologic, Inc.
    8. Carestream Health Inc.
    9. Stryker Corporation
    10. Olympus Corporation
    Frequently Asked Questions
    How big is the Asia Pacific Diagnostic Imaging Market?

    The Asia Pacific Diagnostic Imaging Market is valued at US$ 7,818.99 Million in 2021, it is projected to reach US$ 11,572.58 Million by 2028.

    What is the CAGR for Asia Pacific Diagnostic Imaging Market by (2021 - 2028)?

    As per our report Asia Pacific Diagnostic Imaging Market, the market size is valued at US$ 7,818.99 Million in 2021, projecting it to reach US$ 11,572.58 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Diagnostic Imaging Market report typically cover these key segments-

  • 设备 (心电图, 起搏器, 支架, 除颤器, 心导管, 导丝, 心脏瓣膜, 事件监视器)
  • 应用 (冠心病, 心脏骤停, 中风, 脑血管心脏病)
  • 最终用户 (医院, 门诊手术中心, 心脏中心)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Diagnostic Imaging Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Diagnostic Imaging Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Diagnostic Imaging Market?

    The Asia Pacific Diagnostic Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • General Electric Company
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • KARL STORZ SE & Co. KG
  • FUJIFILM Holdings Corporation
  • Canon Inc.
  • Hologic, Inc.
  • Carestream Health Inc.
  • Stryker Corporation
  • Olympus Corporation
  • Who should buy this report?

    The Asia Pacific Diagnostic Imaging Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Diagnostic Imaging Market value chain can benefit from the information contained in a comprehensive market report.